A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
NCT00596258
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
11
Enrollment
INDUSTRY
Sponsor class
Conditions
Cervical Intraepithelial Neoplasia
Uterine Cervical Dysplasia
Interventions
DRUG:
A-007
Sponsor
Tigris Pharmaceuticals